N-α-Fmoc-N-ε-1-(4,4-dimethyl-2,6-dioxocyclohex-1 -ylidene)-3-methylbutyl-L-lysine
N-α-Fmoc-N-ε-1-(4,4-dimethyl-2,6-dioxocyclohex-1 -ylidene)-3-methylbutyl-L-lysine
Online Inquiry
| CAT# | CP01445 |
| CAS | 204777-78-6 |
| Synonyms/Alias | 204777-78-6;Fmoc-Lys(Ddiv)-OH;Fmoc-Lys(IvDde)-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)hexanoicacid;N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine;C34H42N2O6;Nalpha-Fmoc-Nepsilon-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine;Fmoc-L-Lys(Ivdde)-OH;29207_ALDRICH;SCHEMBL178768;29207_FLUKA;CTK1A1512;MolPort-003-929-341;AKOS015837177;AKOS015895471;ZINC100008472;RTR-009555;AK-49549;SC-09710;AB0044327;A7927;ST51052987;Y3453;I06-1184;N|A-Fmoc-N|A-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine |
| M.F/Formula | C34H42N2O6 |
| M.W/Mr. | 574.7 |
| Application | Peptide synthesis; Drug screening |
| Abbr | Fmoc-Lys(ivDde)-OH |
Storage | -20℃,dry |
InChI | 1S/C34H42N2O6/c1-21(2)17-28(31-29(37)18-34(3,4)19-30(31)38)35-16-10-9-15-27(32(39)40)36-33(41)42-20-26-24-13-7-5-11-22(24)23-12-6-8-14-25(23)26/h5-8,11-14,21,26-27,35H,9-10,15-20H2,1-4H3,(H,36,41)(H,39,40)/t27-/m0/s1 |
InChI Key | PYCBVLUBTMHNPW-MHZLTWQESA-N |
Canonical SMILES | CC(C)CC(=C1C(=O)CC(CC1=O)(C)C)NCCCCC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 |
Write a review
Ask a question
My Review for N-α-Fmoc-N-ε-1-(4,4-dimethyl-2,6-dioxocyclohex-1 -ylidene)-3-methylbutyl-L-lysine
Required fields are marked with *
×
Ask a Question for N-α-Fmoc-N-ε-1-(4,4-dimethyl-2,6-dioxocyclohex-1 -ylidene)-3-methylbutyl-L-lysine
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
